Co-founder & Chief Business Officer, Human Health Marta Ortega-Valle Marta is a co-founder of GreenLight and leads the company’s Human Health business. Under her leadership, Greenlight is developing a multiple mRNA-based drugs approach, including efforts around rapid pandemic response for vaccine; antibody therapies; affordable gene therapies, for which her group got a grant for SCD from the Gates Foundation; and has closed multimillion dollar deals with industry partners in the pharmaceutical, food, and agricultural space. Since the company’s creation, she has had multiple roles as a founder from business development to fundraising to new business creation. Prior to joining GreenLight, Ortega-Valle was an entrepreneur in residence at Kodiak Venture Partners in Boston, where she started GreenLight with her co-founders Andrey Zarur and James Swartz. She started her career in management, strategy, and technology consulting at Accenture, where she held leadership positions in the US and in Europe, closing and leading consulting engagements for life sciences and consumer goods multinationals. Ortega-Valle was selected to be part of the Accenture IPO team in 2001, then led the Business Intelligence unit in Paris. She is a board member at GaneshaLab and participates in MIT’s Innovation Teams, a flagship program that explores how to take technologies to impact. She holds an MBA from Massachusetts Institute of Technology, Sloan Fellows Program at the Sloan School of Management, and a master’s degree in electrical engineering from ETSEIB (UPC) Engineering School of Barcelona.